In contrast, in astrocytoma SNB19 cells, viral replication was reduced significantly with the most pronounced effects observed for GSK2850163, despite the detection of residual XBP1 at later time points (Figure 5A–F). This evidence concerns the gene XBP1 and astrocytoma (excluding glioblastoma).